BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Nureca Ltd. Share Price

NSE
BSE

NSE : NURECA

BSE : 543264

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹244.90

High

₹294.68

Price Summary

Previous Close ₹275.07
Day's Range ₹244.90 - ₹294.68
Open ₹245.57
52 Week Range ₹204.00 - ₹343.00
Volume 5,04,015
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 1,432.78
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 125.53
TTM EPS (₹) 2.18
P/E Ratio 94.46
Book Value(₹) 1.45
PAT Margin (%) 1.31
Face Value (₹) 10.00
ROCE(%) 3.31
Trade Value ( ₹ in Lacs) 165.40
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 0.00
Price/Earning (TTM) 125.53
TTM EPS (₹) 2.18
P/E Ratio 94.46
Book Value(₹) 1.45
PAT Margin (%) 1.31
Face Value (₹) 10.00
ROCE(%) 3.31

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 1146.4 317.4
Expenses N/A N/A
PBT -4.6 20.51
Operating profit 0.0 0.0
Net profit -6.68 24.67

Shareholding Pattern

Promoters (% Holding)

68.09%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

31.43%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.28%

About Nureca Ltd.

Founded 2016
Managing Director Saurabh Goyal
NSE Symbol NURECA

Latest News

Jul
9
2026
EQUITY Posted on Jul 9th 2026

Nureca informs about disclosures

Nureca has informed that the Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Saurabh Goyal.
The above information is a part of company's filings submitted to BSE.
Read More
Jun
20
2026
EQUITY Posted on Jun 20th 2026

Nureca informs about disclosure

Nureca has informed that the Company has received a communication dated June 19, 2026 from certain members of the Promoter/ Promoter Group regarding execution of a Family Settlement Agreement (FSA) dated June 17, 2026. The Company is not a party to the said FSA. The Company has not independently verified the contents of the FSA and is making this disclosure solely based on information furnished by the concerned Promoter/ Promoter Group for compliance with Regulation 30A of the LODR Regulations. The details as required under LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (Master Circular), are provided in Annexure A.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
10
2026
EQUITY Posted on Jun 10th 2026

Nureca informs about disclosure

Nureca has informed it enclosed disclosure received from Nectar Biopharma, Member of Promoter Group pursuant to Regulation 7(2) of PIT Regulations in respect of disposal of shares of the company through an off-market transaction. The disclosure is not required vide SEBI Circular No. SEBI/HO/ISD/ISD/CIR/P/2020/168 and SEBI/HO/ISD/ISD/CIR/P/2021/617 dated September 09, 2020 and August 13, 2021 respectively.
The above information is a part of company’s filings submitted to BSE.  
Read More
Jul
14
2026
EQUITY Posted on Jul 14th 2026

Aster DM Healthcare informs about disclosures

Aster DM Healthcare has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BCP Asia II Topco IV Pte Ltd & PACs.
The above information is a part of company's filings submitted to BSE.
Read More
Jul
14
2026
EQUITY Posted on Jul 14th 2026

Natco Pharma informs about press release

Natco Pharma has informed that it enclosed the Press Release under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the completion of acquisition of additional 13.25% stake in Adcock Ingram Holdings Proprietary.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Nureca Ltd. ?

The current share price of Nureca Ltd. is ₹275.07 as of 2026-07-14.

The market capitalisation of Nureca Ltd. is ₹261.35 as of 2026-07-14.

The 1-year return of Nureca Ltd. is -12.23% as of 2026-07-14.

The P/E ratio of Nureca Ltd. is 94.46 as of 2026-07-15.

The 52-week high and low of Nureca Ltd. are ₹343.00 and ₹204.00, respectively, as of 2026-07-14.

The dividend yield of Nureca Ltd. is 0.0% as of2026-07-14.

You can buy Nureca Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Nureca Ltd. is Saurabh Goyal.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore